Langenbeck's Archives of Surgery

, 393:705 | Cite as

99Tc Nanocolloid sentinel node procedure in thyroid carcinoma

  • Isabella Merante Boschin
  • Antonio Toniato
  • Andrea Piotto
  • Eric Casal Ide
  • Dario Casara
  • AnnaMaria Guolo
  • Domenico Rubello
  • MariaRosa Pelizzo
Original Article

Abstract

Purpose

The purposes of this study were to investigate the efficacy of radiocolloid lymphoscintigraphy and of handheld gamma probe procedure for sentinel lymph node biopsy (SLNB) in papillary thyroid carcinoma (PTC) and to evaluate its results in clinical staging.

Materials and methods

Sixty-five PTC consecutive patients entered the study. Patients underwent radiocolloid lymphoscintigraphy before surgery. Intraoperative sentinel lymph node (SLN) localization was performed using a handheld gamma probe. They were followed up at 2, 6 months, and yearly.

Results

SLN metastases were diagnosed in 52%. Fifty-one patients underwent ablative 131-I therapy. The mean Tireoglobulin level in N0 vs N1 cases was 2.2 ng/ml vs 4.73 (p = 0.03) and 0.68 vs 2.1 ng/ml (p = 0.005) before and after 131-I therapy, respectively.

Conclusions

In patients classified N0 by SLNB, ablative 131-I therapy could be avoided.

Keywords

Sentinel lymph node Thyroid cancer Node metastases Radiocolloid lymphoscintigraphy 

References

  1. 1.
    Pasieka JL (2001) Sentinel lymph node biopsy in the management of thyroid disease. Br J Surg 88(3):321–322 doi:10.1046/j.1365-2168.2001.01694.x PubMedCrossRefGoogle Scholar
  2. 2.
    Rubello D, Pelizzo MR, Al-Nahhas A et al (2006) The role of sentinel lymph node biopsy in patients with differentiated thyroid carcinoma. Eur J Surg Oncol 32(9):917–921 doi:10.1016/j.ejso.2006.03.018 PubMedCrossRefGoogle Scholar
  3. 3.
    Wiseman SM, Hicks WL Jr, Chu QD et al (2002) Sentinel lymph node biopsy in staging of differentiated thyroid cancer: a critical review. Surg Oncol 11(3):137–142 doi:10.1016/S0960-7404(02)00027-0 PubMedCrossRefGoogle Scholar
  4. 4.
    Delbridge L (2004) Sentinel lymph node biopsy for thyroid cancer: why bother? ANZ J Surg 74(1–2):2 doi:10.1046/j.1445-1433.2003.02939.x PubMedCrossRefGoogle Scholar
  5. 5.
    Kelemen PR, Van Herle AJ, Giuliano AE (1998) Sentinel lymphadenectomy in thyroid malignant neoplasms. Arch Surg 133(3):288–292 doi:10.1001/archsurg.133.3.288 PubMedCrossRefGoogle Scholar
  6. 6.
    Gallowitsch HJ, Mikosch P, Kresnik E et al (1999) Lymphoscintigraphy and gamma probe –guided surgery in papillary thyroid carcinoma: the sentinel lymph node concept in thyroid carcinoma. Clin Nucl Med 24(10):744–746 doi:10.1097/00003072-199910000-00002 PubMedCrossRefGoogle Scholar
  7. 7.
    Rettenbacher L, Sungler P, Gmeiner D et al (2000) Detecting the sentinel lymph node in patients with differentiated thyroid carcinoma. Eur J Nucl Med 27(9):1399–1401 doi:10.1007/s002590000286 PubMedCrossRefGoogle Scholar
  8. 8.
    Carcoforo P, Feggi L, Trasforini G et al (2007) Use of preoperative lymphoscintigraphy and intraoperative gamma probe detection for identification of the sentinel lymph node in patients with papillary thyroid carcinoma. EJSO 33(9):1075–1080PubMedGoogle Scholar
  9. 9.
    Chen SL, Iddings DM, Scheri RP et al (2006) Lymphatic mapping and sentinel node analysis: current concepts and applications. CA Cancer J Clin 56(5):292–309PubMedCrossRefGoogle Scholar
  10. 10.
    Pelizzo MR, Rubello D, Merante Boschin I et al (2007) Contribution of SLN investigation with 99m Tc-nanocolloid in clinical staging of thyroid cancer: technical feasibility. Eur J Nucl Med Mol Imaging 34(6):934–938 doi:10.1007/s00259-006-0316-y PubMedCrossRefGoogle Scholar
  11. 11.
    Rubello D, O’Doherty MJ (2006) Sentinel lymph node biopsy in differentiated thyroid cancer: standard of care or experimental tool? Nucl Med Commun 27(11):833–835 doi:10.1097/MNM.0b013e328011022c PubMedCrossRefGoogle Scholar
  12. 12.
    Mazzaferri EL, Kloos RT (2001) Clinical review 128: current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 86(4):1447–1463 doi:10.1210/jc.86.4.1447 PubMedCrossRefGoogle Scholar
  13. 13.
    Noguchi M, Yamada H, Ohta N et al (1987) Regional lymph node metastases in well-differentiated thyroid carcinoma. Int Surg 72(2):100–103PubMedGoogle Scholar
  14. 14.
    Ahuja S, Ernst H, Lenz K (1991) Papillary thyroid carcinoma: occurrence and types of lymph node metastases. J Endocrinol Invest 14(7):543–549PubMedGoogle Scholar
  15. 15.
    Shaha AR, Shah JP, Loree TR (1996) Patterns of nodal and distant metastasis based on histologic varieties in differentiated carcinoma of the thyroid. Am J Surg 172(6):692–694 doi:10.1016/S0002-9610(96)00310-8 PubMedCrossRefGoogle Scholar
  16. 16.
    Gimm O, Rath FW, Dralle H (1998) Pattern of lymph node metastases in papillary thyroid carcinoma. Br J Surg 85(2):252–254 doi:10.1046/j.1365-2168.1998.00510.x PubMedCrossRefGoogle Scholar
  17. 17.
    Shaha AR (1998) Management of the neck in thyroid cancer. Otolaryngol Clin North Am 31(5):823–831 doi:10.1016/S0030-6665(05)70090-6 PubMedCrossRefGoogle Scholar
  18. 18.
    Machens A, Hinze R, Thomusch O et al (2002) Pattern of nodal metastasis for primary and reoperative thyroid cancer. World J Surg 26(1):22–28 doi:10.1007/s00268–001–0176–3 PubMedCrossRefGoogle Scholar
  19. 19.
    Mirallie E, Visset J, Sagan C (1999) Localization of cervical node metastasis of papillary thyroid carcinoma. World J Surg 23(9):970–973 doi:10.1007/s002689900609 PubMedCrossRefGoogle Scholar
  20. 20.
    Robbins KT, Medina JE, Wolfe GT (1991) Standardizing neck dissection terminology. Official report of the academy’s committee for head and neck surgery and oncology. Arch Otolaryngol Head Neck Surg 117:601–605PubMedGoogle Scholar
  21. 21.
    Robbins KT (1998) Classification of neck dissection. Current concepts and future considerations. Otolaryngol Clin North Am 31:639–655 doi:10.1016/S0030-6665(05)70077-3 PubMedCrossRefGoogle Scholar
  22. 22.
    Voutilainen PE, Siironen P, Franssila KO et al (2003) AMES, MACIS, and TNM prognostic classifications in papillary thyroid carcinoma. Anticancer Res 23(5b):4283–4288PubMedGoogle Scholar
  23. 23.
    Pasieka JL, Rotstein LE (1993) Consensus conference on well-differentiated thyroid cancer: a summary. Can J Surg 36(4):298–301PubMedGoogle Scholar
  24. 24.
    Rigual NR, Anderson GR, Loree TR et al (2005) Molecular prognosticators and genomic instability in papillary thyroid cancer. Laryngoscope 115(8):1479–1485 doi:10.1097/01.mlg.0000172045.38907.52 PubMedCrossRefGoogle Scholar
  25. 25.
    Shaha AR (2007) TNM classification of thyroid carcinoma. World J Surg 31(5):879–887 doi:10.1007/s00268–006–0864–0 PubMedCrossRefGoogle Scholar
  26. 26.
    Grebe SK, Hay ID (1996) Thyroid cancer nodal metastases: biologic significance and therapeutic considerations. Surg Oncol Clin N Am 5(1):43–63PubMedGoogle Scholar
  27. 27.
    Witte J, Schlotmann U, Simon D et al (1997) Significance of lymph node metastases of differentiated thyroid gland carcinomas and C-cell carcinomas for prognosis—a meta-analysis. Zentralbl Chir 122(4):259–265PubMedGoogle Scholar
  28. 28.
    Mazzaferri EL, Jhiang SM (1994) Long term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97(5):418–428 doi:10.1016/0002–9343(94)90321–2 PubMedCrossRefGoogle Scholar
  29. 29.
    Toniato A, Boschin I, Casara D et al (2008) Papillary thyroid carcinoma: factors influencing recurrence and survival. Ann Surg Oncol 15(5):1518–1522 doi:10.1245/s10434–008–9859–4 PubMedCrossRefGoogle Scholar
  30. 30.
    Dixon E, McKinnon G, Pasieka JL (2000) Feasibility of sentinel lymph node biopsy and lymphatic mapping in nodular thyroid neoplasms. World J Surg 24(11):1396–1401 doi:10.1007/s002680010231 PubMedCrossRefGoogle Scholar
  31. 31.
    Arch-Ferrer J, Valazquez D, Fajardo R (2001) Gamboa-Domininguez A, Herrera MF. Accuracy of sentinel lymph node in papillary thyroid carcinoma. Surgery 130(6):907–913 doi:10.1067/msy.2001.118372 PubMedCrossRefGoogle Scholar
  32. 32.
    Rubello D, Nanni C, Merante Boschin I et al (2006) Sentinel lymph node (SLN) procedure with patent V blue dye in 153 patients with papillary thyroid carcinoma (PTC): is it an accurate staging method? J Exp Clin Cancer Res 25(4):483–486PubMedGoogle Scholar
  33. 33.
    Catarci M, Zaraca F, Angeloni R et al (2001) Preoperative lymphoscintigraphy and sentinel lymph node biopsy in papillary thyroid cancer. A pilot study. J Surg Oncol 77(1):21–24 doi:10.1002/jso.1058 PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  • Isabella Merante Boschin
    • 1
  • Antonio Toniato
    • 1
  • Andrea Piotto
    • 1
  • Eric Casal Ide
    • 1
  • Dario Casara
    • 1
  • AnnaMaria Guolo
    • 1
  • Domenico Rubello
    • 1
  • MariaRosa Pelizzo
    • 1
  1. 1.Surgical PathologyUniversity of Padua School of Medicine, Istituto Oncologico Veneto (IOV)PaduaItaly

Personalised recommendations